セルソースの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/03/29 | 3,185 | 3,230 | 3,140 | 3,165 | -55 | -1.7% | 106,900 |
| 2023/03/28 | 3,260 | 3,285 | 3,190 | 3,220 | -50 | -1.5% | 55,800 |
| 2023/03/27 | 3,275 | 3,300 | 3,245 | 3,270 | -65 | -1.9% | 56,000 |
| 2023/03/24 | 3,400 | 3,400 | 3,265 | 3,335 | -40 | -1.2% | 124,800 |
| 2023/03/23 | 3,185 | 3,395 | 3,165 | 3,375 | +175 | +5.5% | 142,800 |
| 2023/03/22 | 3,275 | 3,280 | 3,175 | 3,200 | -5 | -0.2% | 95,600 |
| 2023/03/20 | 3,545 | 3,575 | 3,200 | 3,205 | -290 | -8.3% | 171,700 |
| 2023/03/17 | 3,300 | 3,550 | 3,300 | 3,495 | +250 | +7.7% | 255,600 |
| 2023/03/16 | 3,150 | 3,270 | 3,050 | 3,245 | -15 | -0.5% | 287,300 |
| 2023/03/15 | 3,530 | 3,660 | 3,235 | 3,260 | -160 | -4.7% | 703,200 |
| 2023/03/14 | 3,510 | 3,545 | 3,400 | 3,420 | -80 | -2.3% | 264,000 |
| 2023/03/13 | 3,355 | 3,500 | 3,355 | 3,500 | +80 | +2.3% | 152,300 |
| 2023/03/10 | 3,500 | 3,530 | 3,400 | 3,420 | -75 | -2.1% | 113,400 |
| 2023/03/09 | 3,495 | 3,515 | 3,440 | 3,495 | ±0 | ±0% | 104,200 |
| 2023/03/08 | 3,605 | 3,615 | 3,485 | 3,495 | -135 | -3.7% | 196,100 |
| 2023/03/07 | 3,685 | 3,710 | 3,620 | 3,630 | -20 | -0.5% | 65,300 |
| 2023/03/06 | 3,680 | 3,740 | 3,650 | 3,650 | +30 | +0.8% | 110,600 |
| 2023/03/03 | 3,560 | 3,640 | 3,560 | 3,620 | +60 | +1.7% | 78,000 |
| 2023/03/02 | 3,580 | 3,590 | 3,505 | 3,560 | -55 | -1.5% | 99,700 |
| 2023/03/01 | 3,675 | 3,675 | 3,575 | 3,615 | -90 | -2.4% | 141,500 |
| 2023/02/28 | 3,600 | 3,740 | 3,600 | 3,705 | +115 | +3.2% | 127,500 |
| 2023/02/27 | 3,560 | 3,640 | 3,545 | 3,590 | -15 | -0.4% | 87,400 |
| 2023/02/24 | 3,560 | 3,620 | 3,460 | 3,605 | +45 | +1.3% | 94,100 |
| 2023/02/22 | 3,535 | 3,580 | 3,515 | 3,560 | -40 | -1.1% | 66,400 |
| 2023/02/21 | 3,685 | 3,685 | 3,585 | 3,600 | -60 | -1.6% | 68,500 |
| 2023/02/20 | 3,595 | 3,675 | 3,570 | 3,660 | +110 | +3.1% | 97,200 |
| 2023/02/17 | 3,535 | 3,610 | 3,520 | 3,550 | -15 | -0.4% | 50,300 |
| 2023/02/16 | 3,500 | 3,590 | 3,470 | 3,565 | +65 | +1.9% | 53,500 |
| 2023/02/15 | 3,510 | 3,555 | 3,455 | 3,500 | ±0 | ±0% | 70,200 |
| 2023/02/14 | 3,590 | 3,605 | 3,490 | 3,500 | -50 | -1.4% | 65,400 |
| 2023/02/13 | 3,550 | 3,570 | 3,510 | 3,550 | -40 | -1.1% | 84,400 |
| 2023/02/10 | 3,725 | 3,725 | 3,570 | 3,590 | -145 | -3.9% | 124,800 |
| 2023/02/09 | 3,750 | 3,750 | 3,680 | 3,735 | -15 | -0.4% | 64,200 |
| 2023/02/08 | 3,690 | 3,750 | 3,610 | 3,750 | +75 | +2% | 90,000 |
| 2023/02/07 | 3,655 | 3,680 | 3,625 | 3,675 | +45 | +1.2% | 46,500 |
| 2023/02/06 | 3,600 | 3,675 | 3,580 | 3,630 | +30 | +0.8% | 70,900 |
| 2023/02/03 | 3,660 | 3,660 | 3,580 | 3,600 | -10 | -0.3% | 51,600 |
| 2023/02/02 | 3,605 | 3,660 | 3,605 | 3,610 | -20 | -0.6% | 73,600 |
| 2023/02/01 | 3,670 | 3,690 | 3,620 | 3,630 | ±0 | ±0% | 56,000 |
| 2023/01/31 | 3,645 | 3,665 | 3,555 | 3,630 | -40 | -1.1% | 112,500 |
| 2023/01/30 | 3,745 | 3,745 | 3,640 | 3,670 | -5 | -0.1% | 80,800 |
| 2023/01/27 | 3,690 | 3,790 | 3,660 | 3,675 | +15 | +0.4% | 133,200 |
| 2023/01/26 | 3,700 | 3,725 | 3,610 | 3,660 | -20 | -0.5% | 89,800 |
| 2023/01/25 | 3,645 | 3,775 | 3,585 | 3,680 | +35 | +1% | 199,900 |
| 2023/01/24 | 3,565 | 3,650 | 3,525 | 3,645 | +145 | +4.1% | 156,600 |
| 2023/01/23 | 3,410 | 3,510 | 3,370 | 3,500 | +100 | +2.9% | 137,500 |
| 2023/01/20 | 3,460 | 3,475 | 3,390 | 3,400 | -95 | -2.7% | 181,800 |
| 2023/01/19 | 3,590 | 3,590 | 3,470 | 3,495 | -65 | -1.8% | 128,300 |
| 2023/01/18 | 3,555 | 3,645 | 3,535 | 3,560 | ±0 | ±0% | 125,100 |
| 2023/01/17 | 3,650 | 3,650 | 3,540 | 3,560 | -120 | -3.3% | 126,000 |
501～
550
件表示中 / 1333件
類似銘柄と比較する
現在ご覧いただいている「セルソース」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| セルソース | 63,600円 | - | - | - | 49.42倍 | 2.10倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
| 大幸薬品 | 26,700円 | +0.1% | -70.9% | - | 44.65倍 | 1.81倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
| オンコリス | 52,800円 | +3771.0% | - | - | - | 4.78倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
| ステラファーマ | 33,300円 | +245.7% | - | - | - | 3.68倍 |
|
ステラケミファ系、持分会社に。がん放射線治療用ホウ素医薬品が柱。適応拡大・海外展開注力 |
| ワカモト | 32,100円 | +3.4% | - | - | 55.73倍 | 0.93倍 |
|
「強力わかもと」で有名な一般用医薬品と医家向け眼科薬が柱。乳酸菌やアジア、医療機器育成 |
市場注目の銘柄
チャート関連のコラム
